GT Biopharma Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules.
Clinical-stage Biopharmaceutical Company Announces $3.2M Registered Direct Offering
Clinical-stage Biopharmaceutical Company…
Clinical-stage Biopharmaceutical Company Announces $3.2M Registered Direct Offering
GT Biopharma Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules.